Alkermes plc. (ALKS) Dividend Safety
- Dividend payout ratio · 12 months: Value (m); Formula and calculation Cash dividends paid / net income. Period ending 2026-06-30..
Dividend safety
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Dividend payout ratio · 12 months | (m) | Cash dividends paid / net income. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Dividend payments · 12 months | (m) | |
| Net income · 12 months | 66.16M USD | Net Income (Loss) Attributable to Parent |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Dividend payments · 12 months (USD) | Net income · 12 months (USD) | Dividend payout |
|---|---|---|---|
| 2026-06-30 | (m) | $66.16M | (m) |
| 2026-03-31 | (m) | $152.76M | (m) |
| 2025-12-31 | (m) | $241.66M | (m) |
| 2025-09-30 | (m) | $338.83M | (m) |
| 2025-06-30 | (m) | $348.45M | (m) |
| 2025-03-31 | (m) | $352.71M | (m) |
| 2024-12-31 | (m) | $367.07M | (m) |
| 2024-09-30 | (m) | $333.35M | (m) |
| 2024-06-30 | (m) | $288.72M | (m) |
| 2024-03-31 | (m) | $434.43M | (m) |
| 2023-12-31 | (m) | $355.76M | (m) |
| 2023-09-30 | (m) | $214.72M | (m) |
| 2023-06-30 | (m) | $102.99M | (m) |
| 2023-03-31 | (m) | $-164.21M | (m) |
| 2022-12-31 | (m) | $-158.27M | (m) |
| 2022-09-30 | (m) | $-129.14M | (m) |
| 2022-06-30 | (m) | $-94.15M | (m) |
| 2022-03-31 | (m) | $-61.65M | (m) |
| 2021-12-31 | (m) | $-48.17M | (m) |
| 2021-09-30 | (m) | $-91.68M | (m) |
| 2021-06-30 | (m) | $-62.83M | (m) |
| 2021-03-31 | (m) | $-94.63M | (m) |
| 2020-12-31 | (m) | $-110.86M | (m) |
| 2020-09-30 | (m) | $-73.57M | (m) |
| 2020-06-30 | (m) | $-126.32M | (m) |
| 2020-03-31 | (m) | $-138.88M | (m) |
| 2019-12-31 | (m) | $-196.62M | (m) |
| 2019-09-30 | (m) | $-200.98M | (m) |
| 2019-06-30 | (m) | $-182.54M | (m) |
| 2019-03-31 | (m) | $-173.20M | (m) |
| 2018-12-31 | (m) | $-139.31M | (m) |
| 2018-09-30 | (m) | (m) | (m) |
| 2018-06-30 | (m) | (m) | (m) |
| 2018-03-31 | (m) | (m) | (m) |
| 2017-12-31 | (m) | $-157.94M | (m) |
| 2016-12-31 | (m) | $-208.44M | (m) |
| 2015-12-31 | (m) | $-227.16M | (m) |
| 2014-12-31 | (m) | $-30.06M | (m) |
| 2013-12-31 | (m) | (m) | (m) |
| 2013-03-31 | (m) | $24.98M | (m) |
| 2012-03-31 | (m) | $-113.68M | (m) |
| 2011-12-31 | (m) | (m) | (m) |
| 2011-09-30 | (m) | (m) | (m) |
| 2011-03-31 | (m) | $-45.54M | (m) |
| 2010-12-31 | (m) | (m) | (m) |
| 2010-09-30 | (m) | (m) | (m) |
| 2010-03-31 | (m) | $-39.63M | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |